For a child with moderate to severe asthma, which medicine might be included in their action plan to relieve acute symptoms?

In the management of moderate to severe asthma, particularly for the relief of acute symptoms, a short-acting bronchodilator is typically included in the action plan. These medications, also known as rescue inhalers, work quickly to relax the smooth muscles of the airways and allow for improved airflow. They are essential for providing immediate relief during an asthma attack or when experiencing acute symptoms such as wheezing, coughing, and shortness of breath.

In contrast, oral corticosteroids are primarily used for their anti-inflammatory effects and are usually reserved for managing more severe exacerbations or for long-term control in certain situations. Long-acting bronchodilators are generally utilized for ongoing control of asthma rather than for immediate symptom relief, as they take longer to onset and are not intended for use during acute episodes. Anticholinergics can provide some bronchodilation but are not the first line of treatment in acute situations compared to short-acting β2-agonists.

This action plan leverages the quick-acting nature of short-acting bronchodilators to ensure that the child can swiftly alleviate distressing symptoms, underscoring their critical role in asthma management.